{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:40:12Z","timestamp":1790174412636,"version":"4.1.0"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T00:00:00Z","timestamp":1547164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.03114","type":"journal-article","created":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T13:48:01Z","timestamp":1547214481000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Dysregulated TRAF3 and BCL2 Expression Promotes Multiple Classes of Mature Non-hodgkin B Cell Lymphoma in Mice"],"prefix":"10.3389","volume":"9","author":[{"given":"Gema","family":"Perez-Chacon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Adrados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria T.","family":"Vallejo-Cremades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Zapata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1750-2187-8-7","article-title":"TRAF molecules in cell signaling and in human diseases","volume":"8","author":"Xie","year":"2013","journal-title":"J Mol Signal."},{"key":"B2","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/978-0-387-70630-6_15","article-title":"Targeting TRAFs for therapeutic intervention","volume":"597","author":"Zapata","year":"2007","journal-title":"Adv Exp Med Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1600-065X.2011.01055.x","article-title":"Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions","volume":"244","author":"Hildebrand","year":"2011","journal-title":"Immunol Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cytogfr.2013.12.002","article-title":"Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions","volume":"25","author":"Yi","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1600-065X.2011.01067.x","article-title":"Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease","volume":"244","author":"Rickert","year":"2011","journal-title":"Immunol Rev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/ni.1819","article-title":"Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines","volume":"11","author":"Tseng","year":"2010","journal-title":"Nat Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/nature04374","article-title":"Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response","volume":"439","author":"Oganesyan","year":"2006","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nature04369","article-title":"Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6","volume":"439","author":"Hacker","year":"2005","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.gene.2012.12.026","article-title":"Identification and characterization of receptor-interacting protein 2 as a TNFR-associated factor 3 binding partner","volume":"517","author":"Cai","year":"2013","journal-title":"Gene"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.4049\/jimmunol.1402851","article-title":"MAVS Promotes inflammasome activation by targeting ASC for K63-linked ubiquitination via the E3 ligase TRAF3","volume":"194","author":"Guan","year":"2015","journal-title":"J Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1600-065X.2011.01045.x","article-title":"The machinery of Nod-like receptors: refining the paths to immunity and cell death","volume":"243","author":"Saleh","year":"2011","journal-title":"Immunol Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1084\/jem.20100703","article-title":"Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling","volume":"207","author":"Zhu","year":"2010","journal-title":"J Exp Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.immuni.2007.07.012","article-title":"Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs","volume":"27","author":"Xie","year":"2007","journal-title":"Immunity"},{"key":"B14","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.1182\/blood-2008-07-165456","article-title":"Lymphocyte-specific TRAF3 transgenic mice have enhanced humoral responses and develop plasmacytosis, autoimmunity, inflammation, and cancer","volume":"113","author":"Zapata","year":"2009","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/cr.2010.177","article-title":"Non-canonical NF-kappaB signaling pathway","volume":"21","author":"Sun","year":"2011","journal-title":"Cell Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3389\/fimmu.2013.00477","article-title":"A Complex Relationship between TRAF3 and Non-Canonical NF-kappaB2 Activation in B Lymphocytes","volume":"4","author":"Lin","year":"2013","journal-title":"Front Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.immuni.2008.01.009","article-title":"TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor","volume":"28","author":"Gardam","year":"2008","journal-title":"Immunity"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1189\/jlb.0111044","article-title":"Enhanced Toll-like receptor (TLR) responses of TNFR-associated factor 3 (TRAF3)-deficient B lymphocytes","volume":"90","author":"Xie","year":"2011","journal-title":"J Leukoc Biol."},{"key":"B19","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.4049\/jimmunol.159.12.5841","article-title":"Immunohistochemical analysis of in vivo patterns of TRAF-3 expression, a member of the TNF receptor-associated factor family","volume":"159","author":"Krajewski","year":"1997","journal-title":"J Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000082100","article-title":"Marginal zone B cell physiology and disease","volume":"8","author":"Lopes-Carvalho","year":"2005","journal-title":"Curr Dir Autoimmun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature14666","article-title":"Non-coding recurrent mutations in chronic lymphocytic leukaemia","volume":"526","author":"Puente","year":"2015","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4930","DOI":"10.1182\/blood-2011-06-359166","article-title":"Alteration of BIRC3 and multiple other NF-kappaB pathway genes in splenic marginal zone lymphoma","volume":"118","author":"Rossi","year":"2011","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ccr.2007.07.003","article-title":"Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma","volume":"12","author":"Keats","year":"2007","journal-title":"Cancer Cell"},{"key":"B24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ccr.2007.07.004","article-title":"Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma","volume":"12","author":"Annunziata","year":"2007","journal-title":"Cancer Cell"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1158\/0008-5472.CAN-08-3701","article-title":"Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia","volume":"69","author":"Braggio","year":"2009","journal-title":"Cancer Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1038\/leu.2009.149","article-title":"Biallelic inactivation of TRAF3 in a subset of B-cell lymphomas with interstitial del(14)(q24.1q32.33)","volume":"23","author":"Nagel","year":"2009","journal-title":"Leukemia"},{"key":"B27","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1182\/blood-2014-10-602714","article-title":"Genetic inactivation of TRAF3 in canine and human B-cell lymphoma","volume":"125","author":"Bushell","year":"2015","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/leu.2011.309","article-title":"Specific deletion of TRAF3 in B lymphocytes leads to B-lymphoma development in mice","volume":"26","author":"Moore","year":"2012","journal-title":"Leukemia"},{"key":"B29","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.it.2009.06.003","article-title":"Induction of autoimmunity by pristane and other naturally occurring hydrocarbons","volume":"30","author":"Reeves","year":"2009","journal-title":"Trends Immunol."},{"key":"B30","first-page":"227","article-title":"Mouse plasmacytoma: an experimental model of human multiple myeloma","volume":"86","author":"Gado","year":"2001","journal-title":"Haematologica"},{"key":"B31","doi-asserted-by":"publisher","first-page":"16600","DOI":"10.1073\/pnas.0407541101","article-title":"TNF receptor-associated factor (TRAF) domain and Bcl-2 cooperate to induce small B cell lymphoma\/chronic lymphocytic leukemia in transgenic mice","volume":"101","author":"Zapata","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.4049\/jimmunol.1200814","article-title":"TNFR-associated factor 2 deficiency in B lymphocytes predisposes to chronic lymphocytic leukemia\/small lymphocytic lymphoma in mice","volume":"189","author":"Perez-Chacon","year":"2012","journal-title":"J Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1586\/17474086.2015.1026321","article-title":"Therapeutic targeting of Bcl-2 family for treatment of B-cell malignancies","volume":"8","author":"Huang","year":"2015","journal-title":"Expert Rev Hematol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/leu.2011.378","article-title":"BCL2 mutations in diffuse large B-cell lymphoma","volume":"26","author":"Schuetz","year":"2012","journal-title":"Leukemia"},{"key":"B35","doi-asserted-by":"publisher","first-page":"11376","DOI":"10.1073\/pnas.89.23.11376","article-title":"Differential effects of Bcl-2 on B and T lymphocytes in transgenic mice","volume":"89","author":"Katsumata","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"B36","first-page":"6529","article-title":"Differential expression of the Bcl-2 proto-oncogene in neuroblastoma and other human tumor cell lines of neural origin","author":"Reed","year":"1991","journal-title":"Cancer Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"W503","DOI":"10.1093\/nar\/gkn316","article-title":"IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis","volume":"36","author":"Brochet","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1101\/pdb.prot5633","article-title":"IMGT\/V-QUEST: IMGT standardized analysis of the immunoglobulin (IG) and T cell receptor (TR) nucleotide sequences","volume":"2011","author":"Giudicelli","year":"2011","journal-title":"Cold Spring Harbor Protocol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"11713","DOI":"10.1073\/pnas.0604564103","article-title":"B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia","volume":"103","author":"Yan","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.cellsig.2004.05.001","article-title":"What turns CREB on?","volume":"16","author":"Johannessen","year":"2004","journal-title":"Cell Signal."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1182\/blood-2017-11-764332","article-title":"Genetics of diffuse large B-cell lymphoma","volume":"131","author":"Pasqualucci","year":"2018","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1182\/blood-2016-08-733469","article-title":"Crebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice","volume":"129","author":"Garcia-Ramirez","year":"2017","journal-title":"Blood"},{"key":"B43","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nri2998","article-title":"Expanding TRAF function: TRAF3 as a tri-faced immune regulator","volume":"11","author":"Hacker","year":"2011","journal-title":"Nat Rev Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e1002747","DOI":"10.1371\/journal.ppat.1002747","article-title":"Proteomic profiling of the TRAF3 interactome network reveals a new role for the ER-to-Golgi transport compartments in innate immunity","volume":"8","author":"van Zuylen","year":"2012","journal-title":"PLoS Pathog."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1016\/j.bbagen.2016.05.021","article-title":"TRAF3 signaling: competitive binding and evolvability of adaptive viral molecular mimicry","volume":"1860","author":"Guven-Maiorov","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1182\/bloodadvances.2017009670","article-title":"The oncogenic membrane protein LMP1 sequesters TRAF3 in B-cell lymphoma cells to produce functional TRAF3 deficiency","volume":"1","author":"Bangalore-Prakash","year":"2017","journal-title":"Blood Adv."},{"key":"B47","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1600-065X.2012.01115.x","article-title":"Contribution of Toll-like receptor signaling to germinal center antibody responses","volume":"247","author":"DeFranco","year":"2012","journal-title":"Immunol Rev."},{"key":"B48","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.immuni.2011.01.011","article-title":"Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response","volume":"34","author":"Hou","year":"2011","journal-title":"Immunity"},{"key":"B49","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1146\/annurev-immunol-051116-052510","article-title":"Self-reactive B cells in the germinal center reaction","volume":"36","author":"Brink","year":"2018","journal-title":"Annu Rev Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.coi.2015.01.018","article-title":"B cells take the front seat: dysregulated B cell signals orchestrate loss of tolerance and autoantibody production","volume":"33","author":"Jackson","year":"2015","journal-title":"Curr Opin Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nri.2017.24","article-title":"Altered B cell signalling in autoimmunity","volume":"17","author":"Rawlings","year":"2017","journal-title":"Nat Rev Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.celrep.2018.06.046","article-title":"B-cell-intrinsic type 1 interferon signaling is crucial for loss of tolerance and the development of autoreactive B cells","volume":"24","author":"Domeier","year":"2018","journal-title":"Cell Reports"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.4161\/cc.28895","article-title":"The TRAF3 adaptor protein drives proliferation of anaplastic large cell lymphoma cells by regulating multiple signaling pathways","volume":"13","author":"Muro","year":"2014","journal-title":"Cell Cycle"},{"key":"B54","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/imr.12299","article-title":"TRAF3, ubiquitination, and B-lymphocyte regulation","volume":"266","author":"Lin","year":"2015","journal-title":"Immunol Rev."},{"key":"B55","doi-asserted-by":"publisher","first-page":"11324","DOI":"10.1073\/pnas.1509968112","article-title":"Induction of USP25 by viral infection promotes innate antiviral responses by mediating the stabilization of TRAF3 and TRAF6","volume":"112","author":"Lin","year":"2015","journal-title":"Proc Natl Acad Sci USA."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.03114\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T23:59:18Z","timestamp":1720915158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.03114\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,11]]},"references-count":55,"alternative-id":["10.3389\/fimmu.2018.03114"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.03114","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,11]]},"article-number":"3114"}}